Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secretion ex vivo. Overall, reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function.

Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secre-tion ex vivo. Overall, reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function.
Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...

Reduced circulating sphingolipids may indicate a high risk of GDM- to - T2D progression and reflect deficits in CERS2 activity that negatively affect glucose homeostasis and β cell function. Gestational diabetes mellitus (GDM), a transient form of diabetes that resolves postpartum, is a major risk factor for type 2 diabetes ( T2D ) in women.
Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion Authors: Khan, Saifur R;Gunderson, Erica P;Wheeler, Michael B; et al.

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...
Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion
Researchers examined whole-body ceramide synthase 2 ( Cers2 ) knockout and rs267738 knock-in mice. Both models exhibited glucose intolerance and impaired insulin secretion in vivo. Islets isolated from these models also demonstrated reduced β cell function, as shown by decreased insulin secretion ex vivo.

Reduced circulating sphingolipids and CERS2 activity are linked to T2D ...
To explore the role of the CERS2 gene, specifically the rs267738 allele, in glucose regulation and beta-cell function. To establish reduced sphingolipids as a potential biomarker for T2D risk after GDM.
Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion by Cyrus Huneycutt | Feb 12, 2025 | 0 comments
PDF The progression from gestational diabetes to type 2
More information: Saifur R. Khan et al, Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and impaired insulin secretion, Science Advances (2025).






Defects in sphingolipid metabolism were further implicated by integrating metabolomics and genome-wide association data, which identified two significantly enriched T2D - linked genes, CERS2 and CERS4. Follow-up experiments in mice and cells demonstrated that inhibiting sphingolipid metabolism impaired pancreatic β cell function.